Aflac Incorporated Announces Third Quarter 2026 Results, Declares Fourth Quarter Dividend

Aflac's Q3 net earnings plunged 81%, driven by large investment losses and weaker revenues.

What the company is saying

Aflac Incorporated presents its third quarter 2026 results as resilient, emphasizing continued adjusted earnings strength and a 44-year streak of dividend increases. The company highlights a $1.1 billion capital return to shareholders, split between $804 million in share repurchases and $305 million in dividends. Leadership, via Chairman and CEO Daniel P. Amos, frames the quarter as solid despite headwinds, attributing declines to strategic portfolio repositioning, realized investment losses, and currency effects. The narrative stresses ongoing product innovation in Japan (Anshin Palette, Miraito, Tsumitasu) and a focus on profitable growth in the U.S. The announcement acknowledges significant investment losses, a $51 million tax capital loss valuation allowance, and the negative impact of a weaker yen. The tone is measured, with no attempt to obscure the sharp drop in net earnings or the challenges in the Japan segment.

What the data suggests

Net earnings for Q3 2026 fell to $303 million ($0.61 per share) from $1.6 billion ($3.08 per share) a year earlier, an 81.5% decline. Adjusted earnings dropped 8.5% to $1.2 billion, with adjusted EPS down 2.4% to $2.43. Total revenues declined 31% to $3.3 billion, driven by realized investment losses of $1.1 billion, including $842 million from sales and redemptions, $146 million in derivative and FX losses, and $102 million in credit losses. Reserve remeasurement gains of $453 million partially offset these losses. The Japan segment saw a 21% drop in pretax adjusted earnings (to $961 million), with new premium sales down 4% to $118 million. U.S. operations performed better, with net earned premiums up 3.3% and pretax adjusted earnings rising 31.5% to $493 million, benefiting from higher reserve remeasurement gains and lower claims. Shareholders' equity increased to $29.3 billion, but unrealized losses on securities and FX translation widened. The company maintained its dividend growth streak, declaring a $0.61 per share payout for Q4. The data shows a clear deterioration in overall profitability, especially in Japan, with only modest offset from U.S. growth and capital returns.

Analysis

The announcement is a factual quarterly earnings release with no exaggerated or promotional language. All key claims are realised and supported by detailed numerical disclosures, including net earnings, adjusted earnings, revenues, and segment-level results. The tone remains measured, with no forward-looking projections presented as imminent or certain benefits. The only forward-looking statements are generic and not tied to specific financial outcomes. The financial direction is clearly negative, with significant declines in net earnings, revenues, and segment profits, especially in Japan. There is no attempt to inflate the narrative or obscure the deterioration in results, and no large capital outlay is paired with long-dated, uncertain returns.

Risk flags

• ●Investment portfolio risk is elevated, as evidenced by $1.1 billion in net investment losses this quarter, including large realized losses from sales, redemptions, and derivatives. Such volatility can materially impact future earnings and capital levels.
• ●Currency risk remains significant, with a 6.8% weaker yen/dollar exchange rate reducing adjusted EPS by $0.03 in the quarter and $0.10 year-to-date. Continued yen weakness could further erode Japan segment results and consolidated earnings.
• ●Japan segment profitability is under pressure, with pretax adjusted earnings down 21% in dollar terms and new premium sales declining 4%. Structural challenges in the Japanese insurance market and the impact of reinsurance transactions may limit future growth.
• ●Shareholder equity quality is affected by a $5.0 billion net unrealized loss on investment securities and derivatives, up from $1.7 billion a year ago, and a $4.9 billion unrealized FX translation loss. These mark-to-market losses could constrain capital flexibility if realized.
• ●The company’s reliance on reserve remeasurement gains ($453 million this quarter) to support adjusted earnings introduces volatility and may not be sustainable if actuarial assumptions change unfavorably.

Bottom line

Aflac’s third quarter 2026 results reveal a sharp drop in net earnings, primarily due to $1.1 billion in realized investment losses and a 31% decline in revenues. While the company continues to return significant capital to shareholders and maintains its long dividend growth record, underlying profitability is deteriorating, especially in Japan where both earnings and new sales are falling. U.S. operations offer some resilience, but are not enough to offset the broader decline. Currency headwinds and unrealized losses on investments and FX translation further pressure the balance sheet. The company’s narrative is credible, with management directly addressing the causes of underperformance, but the risks to future earnings remain high. Investors should focus on the sustainability of capital returns, the trajectory of Japan segment results, and the potential for further investment and currency-related volatility. The most important takeaway is that headline earnings have dropped precipitously, and recovery will depend on stabilizing investment results and reversing weakness in Japan.

Announcement summary

(NYSE:AFL) Aflac Incorporated reported third quarter 2026 net earnings of $303 million, or $0.61 per diluted share, compared with $1.6 billion, or $3.08 per diluted share, a year ago. Adjusted earnings for the quarter were $1.2 billion, down from $1.3 billion in the prior year, reflecting a decrease of 8.5%. Adjusted earnings per diluted share decreased 2.4% to $2.43. Adjusted earnings benefited from reserve remeasurement gains of $453 million. Annualized return on average shareholders' equity was 4.1%, while annualized adjusted return on equity excluding foreign currency remeasurement was 23.7%. The company returned $1.1 billion to shareholders, including $804 million in share repurchases and $305 million in dividends. Aflac reached 44 consecutive years of dividend increases with the fourth quarter declaration of $0.61 per share. Aflac Japan ceded approximately ¥500 billion of reserves on an FSA basis associated with cancer insurance policies to Aflac Re Bermuda. Total revenues for the quarter were $3.3 billion, down from $4.7 billion in the third quarter of 2025. Net earnings included a $51 million tax capital loss valuation allowance and net investment losses of $1.1 billion, which comprised $842 million in net losses from sales and redemptions, $146 million in losses on derivatives and foreign currency activities, $102 million in current expected credit losses, $1 million in impairments, and a $19 million gain from equity securities. The average yen/dollar exchange rate in the quarter was 158.49, 6.8% weaker than the prior year, negatively impacting adjusted earnings per share by $0.03. Shareholders' equity was $29.3 billion, or $59.08 per share, at September 30, 2026, compared with $28.7 billion, or $54.57 per share, a year ago. Shareholders' equity included a cumulative increase of $12.3 billion for the effect of the change in discount rate assumptions on insurance reserves and a net unrealized loss on investment securities and derivatives of $5.0 billion. For the first nine months of 2026, total revenues were $11.7 billion, down from $12.3 billion, and net earnings were $2.1 billion, or $4.24 per diluted share. Adjusted earnings for the first nine months were $3.0 billion, or $5.92 per diluted share. Adjusted book value excluding AOCI was $26.9 billion, or $54.21 per share, at September 30, 2026. In Japan, third quarter net earned premiums were ¥240.3 billion, down 2.0%, and adjusted net investment income increased 3.7% to ¥101.6 billion. Total adjusted revenues in yen declined 0.3% to ¥343.2 billion, and pretax adjusted earnings declined 15.2% to ¥152.3 billion. In dollar terms, Japan net earned premiums decreased 9.3% to $1.5 billion, and pretax adjusted earnings declined 21.0% to $961 million. For the quarter, total new annualized premium sales in Japan decreased 4.0% to ¥18.8 billion, or $118 million. In the U.S., net earned premiums increased 3.3% to $1.5 billion, and pretax adjusted earnings rose 31.5% to $493 million. U.S. sales increased 3.5% in the quarter to $403 million. For the first nine months, U.S. total new sales increased 3.1% to $1.1 billion. In the Corporate and Other segment, third quarter total adjusted revenues increased 5.0% to $360 million, and pretax adjusted earnings were $72 million. The board declared a fourth quarter dividend of $0.61 per share, payable December 1, 2026, to shareholders of record at the close of business on November 18, 2026.

Disagree with this article?